Modifying the Glycocalyx of Melanoma Cells via Metabolic Glycoengineering

Cell-Based Glycoengineering

Modifying the Glycocalyx of Melanoma Cells <em>via</em> Metabolic Glycoengineering
November 12, 2025
Modifying the Glycocalyx of Melanoma Cells via Metabolic Glycoengineering

On Nov 6, 2024, Harris et al. published a paper in the journal Cells, titled " Modifying the Glycocalyx of Melanoma Cells via Metabolic Glycoengineering Using N-Acetyl-d-glucosamine Analogues". This collaborative research effort, involving experts in synthetic chemistry and cell biology, focused on engineering novel N-Acetyl-D-Glucosamine (GlcNAc) Derivatives. The main finding is that these synthetic analogues—specifically […]

Read More >
Categories
Recent Posts
Engineering <em>E. coli</em> for Enhanced Expression of Glycoconjugate VaccinesEngineering E. coli for Enhanced Expression of Glycoconjugate Vaccines
Glyco-engineering ACE2 for Improved Potency as SARS-CoV-2 Decoy ReceptorGlyco-engineering ACE2 for Improved Potency as SARS-CoV-2 Decoy Receptor
Modifying the Glycocalyx of Melanoma Cells <em>via</em> Metabolic GlycoengineeringModifying the Glycocalyx of Melanoma Cells via Metabolic Glycoengineering
Engineering <em>Escherichia coli</em> for Highly Efficient Production of Lacto-<em>N</em>-triose IIEngineering Escherichia coli for Highly Efficient Production of Lacto-N-triose II
  • twitter
Our Services
Useful Links
Get In Touch
Copyright © CD BioGlyco. All Rights Reserved.
Top